Such mutations may contribute to the high proliferation rate of these tumors, as TP53 encodes p53, a well-known tumor suppressor that stops the cell cycle at the G1/S phase and initiates apoptosis when DNA damage becomes too extensive (39, 44). This evidence concerns the gene TP53 and neoplasm.